High-throughput Spheroid Formation and Migration with TeloCol-10 for Improved Stability
A collaboration between CELLINK, CYTENA and Advanced BioMatrix validates using Advanced BioMatrix’s TeloCol®-10, a high-stiffness collagen, for high-throughput breast cancer cell spheroid formation. This protocol achieves improved stability over longer incubation times vs Matrigel when bioprinting spheroids with TeloCol bioink. Plus, capturing high-resolution images of spheroids with CYTENA’s CELLCYTE X™ live cell imager.
Learn how Advanced BioMatrix’s TeloCol-10:
- Supports both cancer cell spheroid formation and migration with similar growth rates as Matrigel.
- Shows no sign of degradation, while Matrigel presented degradation after 4 to 7 days in both tumor spheroid and cancer cell migration assays.
- Keeps the droplet structure stable over longer incubation times and contains fewer growth factors than Matrigel.
- Is the better choice for high-throughput bioprinting of cancer cell spheroids and migration assays.
- Plus, how to incorporate the CELLCYTE X live cell imager in your workflow for high-resolution imaging.
